申请人:Merck & Co., Inc.
公开号:EP0300726A1
公开(公告)日:1989-01-25
There are disclosed certain 6-piperazino-purine and heteroaromatic derivatives thereof which have oral hypoglycemic activity and with such ability to lower blood sugar are useful in the treatment of type II diabetes and/or obesity with associated insulin resistance. Processes for the preparation of such compounds and compositions containing such compounds as the active ingredient thereof are also disclosed.
已公开的某些 6-哌嗪基嘌呤及其杂芳香族衍生物具有口服降血糖活性,这种降血糖能力可用于治疗 II 型糖尿病和/或伴有胰岛素抵抗的肥胖症。 此外,还公开了制备此类化合物的工艺和含有此类化合物作为其活性成分的组合物。